Ex-Pharma Exec's Contempt Plea Rejected By Judge

By Julie Manganis · April 17, 2024, 3:58 PM EDT

A Massachusetts federal judge on Wednesday rejected a former pharmaceutical executive's agreement to plead guilty to contempt for using an alias to get around a consent judgment in a U.S. Securities...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion
Order

Case Information

Case Title

Case Number

Court

Massachusetts

Nature of Suit

Date Filed

February 21, 2024

Recent Articles By Julie

November 13, 2024
JPMorgan, Health System In Talks To Settle Email Scheme Suit
November 07, 2024
DOL Secretary Seeks Unpaid OT From Health Staffing Cos.
November 06, 2024
Mass. Voters Reject Tipped Minimum Wage Proposal
October 17, 2024
Ex-Genzyme Exec Says Anxiety Disclosure Led To Firing
October 15, 2024
Motley Rice May Avoid DQ In Boston Opioid Case, Judge Hints
October 10, 2024
Teva To Pay $450M To Settle Kickback Cases
October 08, 2024
Mass. Seeks Order Forcing Steward To Maintain Coverage
September 24, 2024
Moderna Execs Hyped Ineffective RSV Vax, Suit Says
September 23, 2024
Mass. General Asks Court To End Fat Removal Patent License
September 18, 2024
Mass. Appeals Court Backs Pot Shop's Arbitration Agreement